Novavax Inc on Thursday started a late-stage trial of its experimental COVID-19 vaccine in the United Kingdom in partnership with the government's Vaccines Taskforce, sending the company's shares up 6 ...

U.S. drug developer Novavax Inc said on Tuesday it was doubling its potential COVID-19 vaccine manufacturing capacity to two billion doses annually under an agreement with Serum Institute of India, ...

Novavax transfers EU rights for Nuvaxovid to Sanofi, earning milestone payments and future royalties. Read more here.

Trump's physician, Sean Barbabella, shared news of the president's COVID vaccination in a letter to White House press ...

Amid confusion over this year's updated COVID-19 vaccines, we explain what's different this year and who experts say should ...

The Centers for Disease Control and Prevention updated its Covid vaccine guidance Monday to recommend Covid shots for people ...

If you are wondering whether it is time to buy, hold, or finally let go of Novavax, you are not alone. The stock has been a wild ride for risk-tolerant investors and cautious traders alike. Just look ...

Novavax ( ($NVAX) ) has issued an update. On October 1, 2025, the European Commission approved the transfer of the marketing authorization for ...

AZ's Board of Pharmacy said pharmacists can administer the new COVID-19 vaccine to anyone ages 6 years of age and older who want it.

The Centers for Disease Control and Prevention on Monday officially recommended updated coronavirus vaccines, creating a new ...

The CDC pulled broad support for COVID-19 shots, saying they should be administered through shared decision-making with a ...